The Solute HR Series comprises a family of liquid chromatography columns built on hybrid organosilica substrates. The range includes HR-C18, HR-C8, HR-Phenyl, and HR-HILIC phases with particle diameters of 1.8 µm, 2.6 µm, and 5 µm, and pore diameters of 100 Å and 300 Å. Column hardware is available in 316L stainless steel or PEEK-lined stainless steel formats, with internal diameters from 2.1 mm to 4.6 mm and lengths from 30 mm to 250 mm. The phases are intended for use under USP <621> and Ph. Eur. 2.2.46 system suitability protocols. The series differs from conventional Type-B silica columns through a total metal content of <10 ppm, a higher ligand bonding density, and a specified operating pH range from 1.5 to 11.0.

How Do Particle Morphology and Bonding Chemistry Influence Retention?

Particle morphology and bonding chemistry interact with the mobile phase to determine retention, efficiency, and peak shape. The 1.8 µm fully porous particle provides a surface area of approximately 220 m²/g and a carbon load of 17–20% for HR-C18. The 2.6 µm superficially porous particle reduces the trans-particle diffusion path and yields a minimum plate height of approximately 4.2 µm for naphthalene under 60/40 acetonitrile/water at 40°C. The 5 µm particle is intended for legacy HPLC instruments with a maximum operating pressure of 400 bar. Ligand bonding uses a trifunctional C18 alkylsilane followed by double endcapping with trimethylsilane; residual silanol concentration is specified at less than 5 µmol/m².

The HR-C8 phase shortens the alkyl chain length to reduce hydrophobic retention; its bonded phase density is specified at 3.0 µmol/m². The HR-Phenyl phase contains a phenylhexyl ligand that introduces π–π selectivity for aromatic positional isomers. The HR-HILIC phase is unendcapped and carries a neutral amide ligand. Separations requiring aqueous mobile phases above 95% should use HR-C18 or HR-C8 with at least 5% organic modifier to avoid phase dewetting in fully aqueous conditions.

When Elevated Chloride Concentrations and Temperature Stress Stainless-Steel Columns

Operation below pH 3.0 with chloride-containing mobile phases accelerates pitting corrosion of standard 316L stainless steel frits and column bodies. For mobile phases containing 0.1 M hydrochloric acid or 0.1 M sodium chloride at pH values below 3.0 and temperatures above 40°C, the PEEK-lined column hardware is specified. The stationary-phase pH range of 1.5–11.0 does not apply to all hardware configurations. Stainless steel columns should not be stored in phosphate-buffered mobile phases above 0.05 M for more than 48 h, because salt precipitation can score the frit and increase inlet clogging. Backpressure increases greater than 15% above the initial value for a defined mobile phase indicate irreversible column blockage or frit fouling.

Thermally accelerated degradation of the bonded phase follows first-order cleavage kinetics with an activation energy of 60–80 kJ/mol for alkylsilane phases. At 80°C in pH 2.0 phosphate buffer, the HR-C18 bonded phase has a manufacturer-specified half-life of at least 300 h. The hybrid substrate contains ethylene bridges in the silica matrix and reduces dissolution at high pH. Continuous exposure at pH 11.0 with 20 mM ammonium hydroxide should not exceed 72 h per batch validation cycle.

The inlet frit is a 0.5 µm porosity titanium frit on the 1.8 µm columns and a 2.0 µm frit on the 5 µm columns. The frit prevents particle extrusion but is the primary site for clogging when unfiltered samples or precipitated buffer salts enter the column. A 0.2 µm syringe filter is recommended for samples with visible turbidity. The maximum backpressure for the 1.8 µm HR column is 1000 bar at 25°C; at 80°C the pressure limit is derated to 800 bar due to thermal expansion of the column hardware and reduced solvent viscosity.

In pharmaceutical impurity profiling, the 2.1 × 100 mm, 1.8 µm HR-C18 column is typically operated at a flow rate of 0.30 mL/min with a column temperature of 40°C. A gradient from 5% to 95% acetonitrile in 0.1% formic acid over 12 min separates critical process impurities from the active pharmaceutical ingredient. System suitability under USP <621> requires a relative standard deviation of no more than 2.0% for six replicate injections, a tailing factor between 0.8 and 2.0, and a column plate count greater than 150,000 plates/m for the probe analyte. The low-pH mobile phase suppresses ionisation of acidic impurities, and the hybrid substrate reduces peak tailing often observed on metal-containing silica for chelating compounds.

For polar metabolite quantitation in environmental water extracts, the HR-HILIC phase with 2.6 µm particles is used under isocratic conditions of 75/25 acetonitrile/20 mM ammonium formate at pH 3.5. The neutral amide stationary phase retains small polar acids via hydrogen bonding and partitioning into the water-rich layer, with an observed retention time relative standard deviation below 1.0% across 500 consecutive injections. The method is compatible with electrospray ionisation mass spectrometry because the buffer concentration is kept at 20 mM to suppress ion suppression while avoiding salt crystallisation in the source. Published multi-laboratory reproducibility data for this specific configuration are limited, so method transfer should be verified by system suitability testing under 21 CFR Part 11 compliant chromatography data systems.

In quantitative bioanalysis of basic drugs in plasma, the HR-C18 2.1 × 50 mm, 1.8 µm column is operated at 0.40 mL/min with a total runtime under 3 min. The mobile phase containing 0.1% formic acid and 10 mM ammonium formate is selected to control the ionisation state of weakly basic analytes. The method is transferred to LC-MS/MS with an electrospray ionisation source operating at 550°C. The short column length reduces residence time and minimises backpressure to under 500 bar at 40°C, while maintaining a plate count above 25,000 plates/column. Deuterated internal standards correct matrix effects; relative standard deviations for extraction replicates remain below 6.0%.

Column Regeneration, Solvent Compatibility, and Batch-to-Batch Controls

Routine storage after use is 70/30 acetonitrile/water for reverse-phase columns and 75/25 acetonitrile/20 mM ammonium formate for the HILIC phase. Inlet fouling is addressed by backflushing with 20 column volumes of the storage solvent at a flow rate not exceeding 0.2 mL/min for a 2.1 mm internal diameter column. PEEK-lined hardware is not compatible with pure tetrahydrofuran, dimethyl sulfoxide above 80%, or chlorinated solvents such as dichloromethane; PEEK swelling can create flow channels and shift retention times. The use of a guard column with the same particle diameter and chemistry is recommended when particle-containing sample extracts are injected.

Before first use, the column should be flushed with 20 column volumes of the intended mobile phase at a flow rate not exceeding 50% of the maximum linear velocity. For HILIC separations, equilibration of the water-rich layer may require between 20 and 80 column volumes after solvent switching from acetonitrile to 20 mM ammonium formate at pH 3.5. Failure to achieve equilibrium is observed as retention time drift exceeding 0.1 min over ten injections.

The product designation identifies the bonded phase, particle diameter, pore size, and hardware format. For example, HR-C18 1.8/100 SS 2.1 × 100 denotes a 1.8 µm fully porous HR-C18 phase with a 100 Å pore diameter in a stainless-steel column of 2.1 mm internal diameter and 100 mm length. PEEK-lined hardware is indicated by a PL suffix. This nomenclature permits direct replacement of an existing column without ambiguity in method records.

The 300 Å pore diameter version is specified for peptides and small proteins with molecular weights up to 40,000 Da. When a 2.1 × 100 mm, 2.6 µm HR-C18 300 Å column is operated at 250 µL/min with 0.1% trifluoroacetic acid and an acetonitrile gradient, the average peak width at half height is below 2.0 s for a 10 µg on-column load of insulin. The larger pore diameter reduces restricted diffusion compared to the 100 Å material. For intact monoclonal antibodies, the 100 Å phase is not recommended because the hydrodynamic radius of an IgG is on the order of 5.5 nm, which approaches the pore exclusion limit and degrades mass transfer.

Relative to conventional Type-B silica columns of equivalent particle diameter, the HR Series hybrid substrate reduces alkaline dissolution and lowers the acidity of residual silanols. This yields reduced tailing for basic analytes without requiring amine additives in the mobile phase. The columns differ from polymer-based reverse-phase media in pressure tolerance and efficiency; the 1.8 µm HR-C18 column retains a maximum pressure rating of 1000 bar, whereas many polymer-based columns are limited to 300 bar. The HR-HILIC phase differs from bare silica HILIC columns through a neutral amide ligand that minimises electrostatic interaction with charged analytes and is compatible with pH 2.0–9.0 mobile phases.

Methods developed on high-purity Type-B silica may show retention time shifts when transferred to the hybrid substrate; a selectivity comparison using the Neue test mixture may be required. The HR-C18 phase meets USP L1 classification, HR-C8 meets USP L7, and HR-Phenyl meets USP L11. The HR-HILIC phase does not have a USP classification and must be validated separately under ICH Q2(R1).

For aflatoxin analysis in nut extracts, the 2.6 µm HR-C18 column with a 100 Å pore size is typically operated with methanol/water acidified with 0.1% acetic acid. Fluorescence detection after post-column derivatisation with bromine is common. System suitability under AOAC Official Method 994.08 requires baseline resolution of aflatoxins B1, B2, G1, and G2. Published multi-laboratory reproducibility data for the HR-C18 configuration are limited, so the column should be qualified with a certified reference material before sample batch analysis.

Batch-to-batch reproducibility is controlled through three production parameters: the silica lot surface area is held within ±5% of the reference value, the carbon load is held within ±0.5 percentage points, and the packing density is verified by pressure drop across a 150 mm column in 80/20 methanol/water at 1.0 mL/min. The column-to-column retention time variation for the HR-C18 phase is specified at less than 2.0% for the test probe. This control is relevant for method transfer between laboratories and for regulatory submissions that require demonstration of equivalent performance under ICH Q2(R1).